miR-21 can promote the proliferation and metastasis of HCC cells by inhibiting the expression of PTEN [177], PDCD4, RECK, and hSulf-1 (human sulfatase-1) [178] and even confer chemotherapy drug resistance to HCC cells [179]. The gene discussed is RECK; the disease is hepatocellular carcinoma.